Sdf1, Sema3A and Sema3F are involved in melanoma, multiple myeloma, glioblastoma, neuroblastoma, pancreatic, prostate, ovarian and lung cancers57–59. The gene discussed is SEMA3F; the disease is plasma cell myeloma.